SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett’s esophagus development
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci190374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Ramon U Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine and. Hauptthemen laut MEDLINE: Barrett Esophagus, SOXB1 Transcription Factors, Homeostasis, Esophageal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Esophageal adenocarcinoma is increasingly prevalent and is thought to arise from Barrett’s esophagus (BE), a metaplastic condition in which chronic acid and bile reflux transforms the esophageal squamous epithelium into a gastric-intestinal glandular mucosa. The molecular determinants driving this metaplasia are poorly understood. We developed a human BE organoid biobank that recapitulates BE’s molecular heterogeneity. Bulk and single-cell transcriptomics, supported by patient tissue analysis, revealed that BE differentiation reflects a balance between SOX2 (foregut/esophageal) and CDX2 (hindgut/intestinal) transcription factors. Using squamous-specific inducible Sox2 -KO ( Krt5 CreER/+ Sox2 Δ/Δ ROSA26 tdTomato/+ ) mice, we observed increased basal proliferation, reduced squamous differentiation, and expanded metaplastic glands at the squamocolumnar junction, some tracing back to Krt5 -expressing cells. CUT&RUN analysis showed SOX2 bound and promoted differentiation-associated targets (e.g., Krt13 ) and repressed proliferation-associated targets (e.g., Mki67 ). Thus, SOX2 is critical for foregut squamous epithelial differentiation, and its decreased expression is likely an initiating step in progression to BE and then to esophageal adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine and.
- Division of Gastroenterology, Department of Medicine, Washington University, St. Louis, Missouri, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
- Section of Gastroenterology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Department of Oncology and.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIMH NIH HHS
- NIH
- U.S. Department of Defense
- American Society of Clinical Oncology
- Baylor College of Medicine
Zitieren
APA
Jin, R. U., Xu, Y., Lih, T. M., Huang, Y. Z., Nittolo, T. M., Sells, B. E., Dres, O. M., Wang, J. S., Li, Q. K., Zhang, H., & Mills, J. C. (2025). SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett’s esophagus development. Journal of Clinical Investigation. https://doi.org/10.1172/jci190374
Vancouver
Jin RU, Xu Y, Lih TM, Huang YZ, Nittolo TM, Sells BE, et al. SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett’s esophagus development. Journal of Clinical Investigation. 2025. doi:10.1172/jci190374
BibTeX
@article{Jin2025,
author = {Jin, Ramon U and Xu, Yuanwei and Lih, T Mamie and Huang, Yang-Zhe and Nittolo, Toni M and Sells, Blake E and Dres, Olivia M and Wang, Jean S and Li, Qing K and Zhang, Hui and Mills, Jason C},
title = {SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett’s esophagus development},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci190374}
}
EUVIMED